Blood vessels form either when dispersed endothelial cells (the cells lining the inner walls of fullyformed blood vessels) organize into a vessel network (vasculogenesis), or by sprouting or splitting of existing blood vessels (angiogenesis). Although they are closely related biologically, no current model explains both phenomena with a single biophysical mechanism. Most computational models describe sprouting at the level of the blood vessel, ignoring how cell behavior drives branch splitting during sprouting.
Introduction

Vasculogenesis and Angiogenesis
Blood-vessel development is essential for myriad biological phenomena in healthy and diseased individuals, including wound healing and tumor growth [1, 2] . Blood vessels form either de novo, via vasculogenesis or by sprouting or splitting of existing blood vessels via angiogenesis.
In vasculogenesis, dispersed endothelial cells (ECs; the cells lining the inner walls of fullyformed blood vessels) organize into a primary vascular plexus of solid cords which then remodel into a vascular network. ECs elongate parallel to the cords, with final aspect ratios of tens to one.
Because the early stages of vasculogenesis depend on a single cell type, vasculogenesis is relatively easy to reproduce in vitro. When cultured in vitro on Matrigel, a commercial product mimicking the extracellular matrix (ECM; the mixture of proteins, growth-factors and carbohydrates surrounding cells in vivo), even in the absence of other cell types or positional cues, ECs organize into cords
Computational Background
Fortunately, a number of models and simulations replicate features of in vitro vascular patterning and can help partially reconstruct minimal sets of behaviors ECs require to self-organize into polygonal, vascular patterns [11, 12, [15] [16] [17] [21] [22] [23] .
Because of the experiments we discussed above and others which have demonstrated that sprouting angiogenesis and vasculogenesis both require chemotaxis (see, e.g., [7, 8, 24] ), most models of vasculogenesis assume that intercellular signaling occurs via a diffusible chemoattractant. Using continuum models deriving from the fluid-dynamic Burgers' equation, Preziosi and coworkers (called the Torino Group in this paper) showed that simulated ECs secreting a chemoattractant that attracts surrounding ECs, could self-organize into polygonal patterns similar to the patterns in EC cultures and in vivo [11, 12, 25, 26] . However, their work assumed that endothelial cells accelerate in chemical gradients, which is not plausible in the highly viscous, noninertial environment of the ECM. Microfluidic evidence indicates that mammalian cells (HL60) rapidly reach a flow-dependent, constant velocity [27] in chemoattractant gradients rather than continuously accelerating. We have previously suggested that [22] a linear force-velocity relation is the most appropriate model of ECs' experimental response, with the velocity of ECs proportional to the strength of the gradient of the chemoattractant. However, in simulations of this simple model, isotropic ECs form well-separated rounded clusters instead of networks. We have shown that adding one of a number of mechanisms (including cell adhesion [21] and cell elongation [22] ) to Contact-inhibited chemotaxis in de novo and sprouting blood vessel growth Roeland Merks et al.
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In the mechanical models of Manoussaki and Murray [15] , and Namy et al. [16] ECs pull on the elastic ECM and aggregate by haptotactically migrating along the resulting ECM stress lines.
Surprisingly, the mathematical form of the chemical and mechanical models is practically identical.
Because these mechanical models assume that ECs exert radially-symmetric stresses on the ECM, modeling stress fields and EC haptotaxis or EC secretion and response to a chemoattractant, results in the same cell movement. Since simulations of the two mechanisms are identical, distinguishing between the effects of chemical and mechanical mechanisms will require additional experiments (such experiments are currently underway in the Glazier laboratory (Shirinifard, Alileche and
Glazier, preprint, 2008)).
A separate set of simulations address angiogenesis. Many models of sprouting blood-vessel growth introduce blood-vessel-level phenomenology by hand through high-level rules for branching [28] [29] [30] . Attempts to derive blood-vessel sprouting and splitting from the underlying behavior of ECs include Levine and coworkers' [31] model of the onset of angiogenic sprouting as a reinforced random walk, where the ECs degrade the ECM, which locally enhances EC motility and produces paths of degraded ECM, and Bauer and Jiang's [32] cell-based model of blood-vessel sprouting along externally-generated morphogen gradients, which assumed that branch splitting results from ECM inhomogeneities. Neither model can explain both EC assembly and blood-vessel sprouting.
Could the behavior of the individual ECs also explain aspects of blood-vessel sprouting?
Because the same genetic machinery regulates both angiogenesis and vasculogenesis [4] , a common set of mechanisms is plausible. Manoussaki [33] extended her mechanical model of vasculogenesis to describe angiogenesis by adding long-range, chemotactic guidance cues. In her simulations, ECs migrated from an aggregate towards a chemoattractant source and cell-traction-driven migration contracted the sprout into a narrow, vessel-like cord. In this paper we present an alternative chemotaxis-based mechanism that can produce networks both from dispersed ECs and EC clusters without requiring long-range guidance cues.
Instead, in our model long-range signals would only steer the self-organized vessels, a more biologically-realistic mechanism. Extending simulations that we have briefly introduced elsewhere [23] , we show that VE-cadherin-mediated contact inhibition of chemotactic pseudopod projections, in combination with secretion of a diffusing, rapidly decaying chemoattractant by ECs, suffices to reproduce aspects of both de novo and sprouting blood-vessel growth. In our simulations ECs: a) secrete a chemoattractant and b) preferentially extend pseudopods up gradients of the chemoattractant, unless, c) contact inhibition locally prevents chemotactic pseudopod extension.
Thus, cell-cell binding suppresses the extension of chemotactic pseudopods, while unbound cell surfaces in contact with the ECM continue to extend pseudopods towards sources of chemoattractant [24] . We compare two biologically-plausible scenarios for chemotaxis, one in which ECs actively extend and retract pseudopods along chemoattractant gradients, and one in which the pseudopods' retractions are chemotactically neutral. The second scenario suggests a sprouting mechanism where a secreted autocrine factor acts both as a long-range chemoattractant and a local inhibitor of pseudopod sprouting.
Results
We modeled endothelial cell behavior at a mesoscopic level using the Glazier-Graner-Hogeweg (GGH) model, also known as the Cellular Potts Model (CPM) [34] [35] [36] [37] . The GGH is a lattice-based
Monte-Carlo approach that describes biological cells as spatially-extended patches of identical lattice indices. Intercellular junctions and cell junctions to the ECM determine adhesive (or binding)
energies. The GGH algorithm, which we describe in more detail in Section 4 (Materials & Methods), models pseudopod protrusions by iteratively displacing cell interfaces, with a preference for displacements which reduce the local effective energy of the configuration. Cells reorganize to favor stronger rather than weaker cell-cell and cell-ECM bonds and shorter rather than longer cell boundaries. In addition to interface displacements that reduce the effective energy, active cell motility also allows displacements that increase the effective energy. The likelihood of these active displacements increases with the cell-motility parameter T. Further constraints regulate cell volumes, surface areas, and chemotaxis. To model chemotaxis, we use the Savill and Hogeweg [36] algorithm that favors extensions of pseudopods up concentration gradients of a chemoattractant (see Eq. 3 in Section 4). In the simplest implementation of chemotaxis in the GGH, cell velocity is proportional to the strength of the chemical gradient, in general agreement with experiments; see e.g. [22] (we discuss the details of chemotaxis implementation below in the subsections 2.5 and 2.6
and in Section 4; see especially Eq. 3).
The advantage of the GGH over alternative cell-based modeling approaches [38] that represent cells as point particles or fixed-sized spheres or ellipsoids is that we can differentiate between bound and unbound regions of cell membrane. The GGH naturally represents the stochastic, exploratory behavior of migrating cells, modeling it as the biased extension and retraction of pseudopods, instead of a biologically-implausible single force acting on cells' centers of mass as in some cell-based simulations.
We described chemoattractant diffusion and degradation macroscopically, using a continuum approximation. In analogy to the Torino Group's continuum model of de novo bloodvessel growth [12, 25] , ECs secrete a diffusing chemoattractant at a rate ! , which degrades in the ECM at a rate ! (e.g. due to proteolytic enzymes or by binding to ECM components), obeying:
where [39] . However, the phenomena we observe in our simulations hold over a large range of diffusion coefficients.
EC aggregation and vasculogenesis in the absence of contact inhibition
In Fig. 1 (A-C) and Movie S1, we randomly distributed 1000 ECs, each with an area of ~200 !m 2 over an area of ! 700 !m " 700 !m ( 333 ! 333 lattice sites, or pixels, of 2 !m ! 2!m each), which we positioned inside a larger lattice of 1000 !m ! 1000 !m to minimize boundary effects. In this cell-based simulation of the Torino Group's continuum model [11, 12] , without endothelial-cell acceleration in chemoattractant gradients our cells form disconnected, vascular islands rather than a vascular network. We would expect this result, because, with the more realistic chemotactic response we employ, the Torino Group's model reduces to the classic Keller-Segel equations [40] of chemotactic aggregation [25] , which, like our simulations, form isolated vascular islands. 
Sprouting angiogenesis in the absence of contact-inhibition
To investigate whether the Torino-Group Model could reproduce sprouting angiogenesis, we started our simulations with rounded clusters of simulated ECs representing a blood vessel's surface after degradation of the ECM, keeping the simulation parameters unchanged from As in vasculogenesis, cell-elongation sufficed to drive angiogenesis-like sprouting (see Fig.   2 (G-I)), where we used a length constraint, see [22] ). EC clusters also produced sprouts for strong cell-cell adhesion (i.e. for values of J(c,c)<10) ( Fig. 2 (A-C)), via a mechanism similar to the cellelongation-dependent mechanism for vasculogenesis [22] . Adhesion-independent sprouting occurred only for a narrow range of very small diffusion constants of the chemoattractant, between
. The allowable range of D increased for bigger cells [23] .
Figs. 7-10 and supplementary Fig. S1 show the results of systematic screens for sprouting in the absence of contact-inhibited chemotaxis, but we defer an in-depth study of these phenomena to our future work. 
Contact-inhibited chemotaxis in de novo blood vessel growth
In this paper, we focus on the role of contact-inhibited chemotaxis in sprouting blood-vessel growth. We hypothesize that VE-cadherin's local inhibition of chemotaxis-induced pseudopod extensions at EC-EC boundaries, may be responsible for ECs' self-organization into vascular-like networks.
We modeled contact inhibition of chemotaxis in our simulations by suppressing chemotaxis at cell-cell interfaces. Thus, only interfaces between cells and ECM respond to the chemoattractant. 
Contact-inhibited chemotaxis in blood vessel sprouting
To investigate the role of contact-inhibited chemotaxis in blood vessel sprouting, we ran a set of simulations with a large cluster of endothelial cells representing a blood vessel's surface after degradation of the ECM, keeping all simulation parameters the same as those in
The surface of the cluster first roughens, with some cells protruding from the surface, then digitates into a structure reminiscent of a primary vascular plexus ( Fig. 4 (A-C) and Movies S4 and S5), the first type of structure to develop in both de novo and sprouting blood-vessel growth [41] . The sprouting instability requires contact inhibition of chemotaxis. Without it, the clusters remained rounded and compact ( Fig. 4(D) ). Thus our simulations suggest that a process operating at the level of individual cells-chemotaxis with contact inhibition-may drive in vitro blood-vessel growth both sprouting and de novo.
What drives blood vessel sprouting in our model? At equilibrium, the chemoattractant has a quasi-Gaussian profile across the cluster. It levels off towards the cluster's center, while its inflection point is at the cluster boundary. Chemotaxis produces a continuous, inward, normal force at the cluster boundary, creating a buckling instability (see e.g. [42] ); chemotactic forces also compress small initial bumps laterally, producing sprouts. Since contact inhibition of chemotaxis leaves the interior cells insensitive to the chemoattractant, ingressing surface cells easily push them aside. When we omit contact inhibition of motility to mimic anti-VE-cadherin-antibody-treated allantois cultures, the interior cells also feel the inward-directed chemotactic forces and resist displacement ( Fig. 4 (D) and Movie S6).
To explore this idea, we varied the ratio of the chemotactic response at cell-cell interfaces To validate our model against published EC tracking experiments [19] , we compared the trajectories of cells in sprouting and non-sprouting clusters. Fig. 6(A-D) show the trajectories of ten cells in a sprouting cluster (with contact-inhibition; panels a-b), and ten cells in a non-sprouting cluster (without contact-inhibition; panels c-d). In non-sprouting clusters, cells followed randomwalk trajectories, while in sprouting clusters, they followed biased random-walk trajectories. To further characterize cell motility, we measured cells' average displacements and velocities over 10 independent simulations of 128 cells each. In sprouting clusters, the cells moved further during a given interval than in non-sprouting clusters. Thus, the cell velocity
is larger during sprouting if the interval !t between subsequent cell positions is sufficiently large (here we use !t = 2.5 h as in Perryn et al. [19] ); for shorter intervals (e.g. 30 s) the cell velocity is highest in non-sprouting clusters (not shown),
indicating that ECs in sprouting clusters moved faster, but had a somewhat slower random motility.
Our simulations agree with recent experiments tracking ECs in embryonic mouse allantoides [19] that measured the cell-autonomous motility of ECs cells in allantoides relative to the motility of the surrounding mesothelium in which the ECs reside. Administration of anti-VE-cadherin antibodies reduced both cell-autonomous motion and net displacement of ECs. Thus, our simulations suggest that VE-cadherin's role as a contact-dependent inhibitor of cell motility suffices to explain the reduced cell motility observed in anti-VE-cadherin-treated allantoides cultures.
Sensitivity analysis
Contact-inhibited sprouting occurs for a wide range of parameter values. In most of our simulations we set the EC-EC adhesion equal to the EC-ECM adhesion (i.e. J(c, c) = 2J(c, M ) ; the factor of 2 arises because we model the ECM as a single large generalized cell), which is equivalent to setting the surface tension of the cluster to zero [35] . Zero surface tension clarifies the role of contact inhibition in sprouting, but real ECs adhere strongly to each other via adherens junctions [18] . In Shirinifard and J. A. Glazier, preprint, 2008) . Higher chemotactic strengths increase ruffling of the cluster boundary, reducing the cluster's compactness in the absence of contact inhibition (Fig. 8) .
We assumed that ECs extend or retract pseudopods depending on the difference in chemoattractant concentration between the retracted and extended positions, independent of the absolute chemoattractant concentrations. However, at higher chemoattractant concentrations, most chemoattractant receptors will saturate with chemoattractant and become insensitive to chemoattractant levels. To study the effect of saturated chemotactic response [21] on angiogenic sprouting, we varied the saturation parameter s (see Eq. 3, Section 4) leaving all other parameters unchanged. For s = 0 , the chemotactic response is linear; for s > 0 , the response to the chemoattractant gradient vanishes at high concentrations (see Section 4). For small positive s, the clusters sprout normally (see Fig. 9 and Movies S9A-C); however, for large s, the chemotactic response weakens at the chemoattractant levels present at the edge of the cell cluster; thus cells no longer chemotact towards the cluster's interior and the sprouting instability disappears (Movies , M ) ) by the same factor, increasing the secretion rate first thins and lengthens the cords by increasing the chemotactic strength, then eventually prevents sprouting as the chemotactic response saturates. This effect is most apparent for s = 0.01 (Fig. S2 , top panel).
In the Torino Group's continuum model, the separation between the cords increases with the diffusion length L of the chemoattractant, Fig. 10 and Movies S10A-G show sprouting clusters for a range of diffusion lengths. In agreement with the Torino Group's model, longer diffusion lengths produce thicker cords with larger intercord spaces. The clusters do not sprout well when L approaches the EC-cluster diameter. Clusters consisting of 1024 cells sprout for
, while 128-cell clusters do not ( Fig. 10 and Movies S11A-G). If the diffusion length is smaller than the ECs' diameter, the clusters dissociate: the ECs perform random walks with long persistence lengths, moving up the chemoattractant gradients they leave behind themselves (Movies S10A and S11A).
A dissipative sprouting mechanism
In our simulations, the trailing edges of the ECs retract actively in response to the chemoattractant and exert an inward-normal, compressive force on the EC cluster. To check if sprouting requires this compressive force, we also simulated a situation in which only extending pseudopods at cell-ECM interfaces respond to the chemoattractant, while retraction is chemotactically neutral. Both sprouting-angiogenesis and vasculogenesis occurred, but required higher intrinsic cell motilities
(larger values of the parameter T ). Fig. 11 shows the motilities required under both assumptions. We looked for sprouting after 5000 MCS (~ 40 h) in clusters of 128 cells, each of area ! 200 !m 2 , placed in a 400 !m ! 400 !m lattice, with all other parameters the same as in Fig. 4 . For 100 T < , our original chemotaxis assumptions produced sprouts, while no sprouting occurred if pseudopods responded to the chemoattractant only during extension. For 100 < T < 400 , both mechanisms produced sprouts. For 400 T > , the ECs broke up into small pieces, a well-characterized, nonbiological artifact of the GGH [35] . With extension-only chemotaxis, sprouting was slightly slower than for standard, extension-retraction Savill-Hogeweg [36] chemotaxis, as a plot of the time evolution of the clusters' compactness shows ( Fig. 12 and Movies S12-S14). However, at long times ( 2500 MCS t > ) the compactness of clusters decreased at identical rates for both methods.
These results suggest an additional mechanism for blood-vessel sprouting: at the cluster surface, all pseudopod extensions increase the effective energy slightly, so the chemoattractant inhibits pseudopod extension. A recent experimental study [43] found that autocrine secretion of the sprouting inhibitor TGF-!1 enhances branching in mammary epithelial tubes. Our model suggests a mechanism by which an autocrine, secreted chemical can act both as a chemoattractant and as an inhibitor. The rates of pseudopod extensions and retractions are critical to pattern evolution (Fig.   11 ). Cells in growing tips see a shallower gradient than do those in valleys between the tips (see e.g. Fig. 4(B) ), so pseudopod extensions at growing tips are more frequent than in the valleys between tips because they have a lower effective-energy cost. During sprouting, conservation of cell area requires that the cells in the valleys must retract, while those in the tips protrude. In the SavillHogeweg algorithm, retraction is energetically favorable, while it is energetically neutral in our pseudopod-extension-only chemotaxis algorithm, making the net change in effective energy positive with a rate depending on the cell motility. The effective-energy change is negative in the Savill-Hogeweg algorithm and thus nearly independent of T ( Fig. 13 where 0 H is the initial effective energy). 
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Discussion
We have shown that a single set of cell behaviors, i.e. contact-inhibited chemotaxis to an autocrine, secreted chemoattractant can explain aspects of both de novo and sprouting blood-vessel growth.
Our results suggest that branching in aggregates of chemotacting ECs could result from two separate effects of the same mechanism. For low cell motilities T, i.e. a low probability for active, dissipative cellular protrusion, the branching resembles a buckling instability (see e.g. [42] ), in which the surface cells exert a surface-normal force on the cluster's inner core. For larger cell motilities, the shallower chemoattractant gradients at protrusions make the ECs there more likely to extend outward-directed pseudopods than cells in the valleys between the protrusions.
While we have adopted the Torino Group's assumption that ECs chemotax in response to gradients of a diffusible, autocrine, secreted chemoattractant [12, 25] , our simulation also reproduces continuum models that assume that ECs stress the ECM [15] , which either pulls on the surrounding ECs, provides haptotactic cues for active EC migration [16] , or both [26] . Because these models assume that ECs exert radially-symmetric stresses on the ECM, the underlying mathematical descriptions of the chemotactic and haptotactic mechanisms are equivalent. In both cases, contact inhibition should still operate and the patterning mechanism we have proposed should still apply, with traction or haptotaxis replacing chemotaxis and the mechanical screening length replacing the diffusion length. Our simulation may also apply to the formation of linear structures by nonvascular, glia or muscle cells cultured on rigid, plastic culture dishes in continuously-shaken medium [17] in which cells explore their environment using long filopodia, then move towards their neighbors by pulling themselves along bound filopodia. Thus, the combination of cell aggregation and contact-inhibition that drives patterning in our model, could also occur without chemical gradients and even without ECM.
Our simulations also allow us to clarify a number of subtleties concerning the interpretation of our own and others' experiments in which blocking VE-cadherin interfered with normal vascular patterning. In our in vitro experiments, anti-VE-cadherin treatment caused ECs to round, in addition to its hypothesized effect on contact inhibition, so our experiments cannot rule out the possibility that the anti-VE-cadherin treatment inhibited vascular patterning because of its effect on EC shape.
A further complication is that anti-VE-cadherin treatment could conceivably reduce the adhesion between ECs. As we noted above, In VE-cadherin -/-knock-out mice, ECs still form strong adhesive junctions [18] , suggesting that VE-cadherin is not required for EC-EC binding.
Our simulations show that the contact-inhibition patterning mechanism operates over a wide range of cell-cell adhesions, suggesting that changes in adhesivity are not significant provided that contact-inhibition persists, and independent of cell shape [23] , suggesting that the shape change is not significant. However, we have also shown that strong cell-cell adhesion plus chemotaxis can produce vascular-like patterns in simulations [21] . Fortunately, the three vascular patterning mechanisms (contact-inhibition, cell-elongation and cell-cell adhesion) have vastly different kinetics [22] . Thus time-lapse microscopy experiments [19, 44] quantifying the kinetics of capillaryplexus development (see e.g. [22] ), will allow us to definitively distinguish among these three patterning mechanisms. Already, we can say that adhesion-driven patterning is so slow and requires such strong adhesion that it appears incompatible with the available qualitative data from experiments.
To further test if VE-cadherin-mediated, contact-dependent signaling to VEGF-R2 [20] , rather than VE-cadherin's function as a cell-adhesion molecule is responsible for the effects of anti-VE-cadherin treatment in mouse yolk sacs, we could experimentally block signal transduction from VE-cadherin to VEGFR-2, specifically interfering with VE-cadherin's signaling function, while leaving its role as an adhesion molecule intact. A possible target would be CD148, which phosphorylates VEGFR2 after VE-cadherin binding [20, 45] . Embryonic vascularization and angiogenic sprouting are severely deficient in CD148 -/-knock-out mice [45] , further supporting our hypothesis that VE-cadherin's contact-dependent intercellular signaling is crucial to vasculogenesis and angiogenesis. Perryn et al. [19] showed that anti-VE-cadherin treatment reduced sprout extension in murine allantois cultures by 70%, while it reduced cell-autonomous motility along sprout segments by 50 %. Based on these results, they postulated that VE-cadherin is required for the motility of ECs along sprouts towards the tip. However, our simulations show that the observed cell slowdown after anti-VE-cadherin administration may be an indirect effect of a reduction of sprouting.
Furthermore, our simulations suggest that even substantially reduced cell motility may not prevent patterning, though it does slow it down.
In our simulations, branching and pattern formation require only experimentally-observed cell-level mechanisms, instead of the blood-vessel-level phenomenology in some other angiogenesis models [28] [29] [30] . However, by starting with a cluster of endothelial cells, our simulations ignore many events preceding sprout formation, including the release of plasma proteins by the vessel, the breakdown of the basal lamina, the detachment of the ECs from surrounding ECs and smooth muscle cells, and cell proliferation. They also ignore subsequent processes consolidating outgrowth of the sprout, including tip-cell selection, any long-range chemoattractants and chemorepellants that guide the vessel to its target, the formation of new basal lamina, the sprout's association with stabilizing cells including pericytes, lumen formation within the sprout, and flow-induced remodeling of the developed vasculature. The mechanism for sprouting and network formation we have proposed forms a firm basis for future, more complete models of angiogenesis which include basal lamina and pericytes. We are currently studying the formation of directed sprouts with proliferating ECs in response to additional chemoattractants or chemorepellants and analyzing the role of cell elongation during sprouting. We are also studying the effect of additional, cell-cell contact-dependent signaling mechanisms, including delta-notch tip-cell selection [3] and chemoattractant-response amplifying Eph receptor-ephrin ligand interactions [8] .
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Materials and Methods
The Glazier-Graner-Hogeweg (GGH) Model
The GGH represents biological cells as patches of identical lattice indices ( ) x ! ! on a square or triangular lattice, where each index uniquely identifies, or labels a single biological cell.
Connections (links) between neighboring lattice sites of unlike index ( ) ( ) 
where x ! and x! ! are neighboring lattice sites (up to fourth-order neighbors), a is the current area of cell ! , target ( ) A ! is its target area, ! represents a cell's resistance to compression, and the Kronecker delta is ( ) {1 0 } x y x y x y ! , = , = ; , " . Each lattice site represents an area of 2 !m ! 2 !m .
Since we assume that ECs do not divide or grow during patterning, we set A target (! ) = 50 lattice sites, corresponding to a cell diameter of about 16 !m , and 25 ! = for all cells. The ECs reside in a very thin layer of extracellular fluid, which is a generalized cell without a volume constraint and with 0 ! = . We assume that the ECs and fluid sit on top of a rigid ECM through which the chemoattractant diffuses, but we do not represent this ECM in the GGH lattice. We also assume that the presence of the fluid does not disturb the chemoattractant distribution in the ECM. Unless we specify otherwise, we use a bond energy ( ) 40 J c c , = between the ECs, and ( special, high cell-border energy ( ) 100 J c B , = to prevent ECs from adhering to the lattice boundaries. We use fixed boundary conditions.
To mimic cytoskeletally-driven pseudopod extensions and retractions, we randomly choose a source lattice site x ! , and attempt to copy its index ( ) x ! ! into a randomly-chosen neighboring lattice site x! ! . For better isotropy we select the source site from the twenty, first-to fourth-nearest neighbors [46] . During a Monte Carlo
Step (MCS) we carry out N copy attempts, with N the number of sites in the lattice. We set the experimental time per MCS to 30 s ; for this setting the simulated ECs move with nearly their experimental velocity [22] . We calculate how much the effective energy would change if we performed the copy, and accept the attempt with probability In experiments, cells respond to chemoattractant gradients by executing a more-or-lessstrongly biased random walk up or down the gradient, where, over times short enough to allow us to neglect adaptation, the velocity of the drift depends on the gradient strength and the absolute concentration. We therefore define a set of extensions to the basic GGH model which reproduce these empirical behaviors due to preferential extension and retraction of pseudopods up chemoattractant gradients [24] by including a chemical effective-energy change at each copy attempt [21, 36] ,
where c is the concentration of the chemoattractant, which we assume is present everywhere in a layer of ECM under the ECs, x! ! is the target site, x ! the source site, and s regulates the saturation of the chemotactic response. Unless we specify otherwise, we set s = 0 , in which case chemotaxis depends linearly on the chemoattractant gradient only, independent of the chemoattractant 
.
For a more detailed discussion of chemotaxis in the GGH model see [47] . We solve the partialdifferential equation for chemoattractant diffusion and degradation (Eq. 1) numerically using a finite-difference scheme on a lattice matching the GGH lattice. We use 15 diffusion steps per MCS, with !t = 2 s . For these parameters, the chemoattractant diffuses more rapidly than the ECs, enabling us to ignore advection in the medium as the cells push the fluid. 
Allantois Culture and Immunolabeling
We dissected allantoides from mouse embryos at embryonic stages 7.5-8.0. We washed the explants in fresh, cold ePBS and pipetted them into fibronectin-coated (5 mg/ml ) Delta-T culture dishes and 1% L-glutamine (GibcoBRL, Grand Island, NY). We maintained the allantoic explants using standard culture conditions (37 o C and 5% CO 2 / 95% air atmosphere) in a custom-designed culture chamber for 12-24 hours in the presence of an endothelial-specific marker, CD34 monoclonal antibody (BD PharMingen, San Diego, CA) directly conjugated to Cy3 (Amersham Biosciences).
We fixed the allantoides in 3% paraformaldehyde for 20 minutes at room temperature, followed by an ePBS wash. For VE-cadherin antibody perturbations, we added anti-VE-cadherin monoclonal antibody (BD PharMingen, San Diego, CA) at 25 !g / ml to the culture medium.
Image Acquisition
We observed the cultures with a 10 ! objective (0.30 N.A.) on an inverted, automated, wide-field, epifluorescence/differential-interference-contrast (DIC) microscope (Leica DMIRE2, Leica
Microsystems, Germany). We recorded images ( 608 ! 512 pixel spatial and 12-bit intensity resolution) with a cooled Retiga 1300 camera (QImaging, Burnaby, British Columbia) in 2 ! 2 binned acquisition mode, using 100-300 ms exposures. Image acquisition and microscope settings used software described in [44] .
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